Douglas R Lowy

This inventor holds 25 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 2 EPO patents, primarily in Papillomavirus Research. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America as Represented by the Department of Health, Johns Hopkins University. Active years: 1995-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Douglas R Lowy. Retrieved from https://idiyas.com/inventor/douglas-r-lowy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 25 (Patent Applications = 5)

% Patents Active = 76.0

CIPO Patents = 4

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 260(Granted Patents)

Location History:

Washington, DC (US) (1995 - 2008)
Bethesda, MD (US) (1997 - 2020)

Company Filing History:

15 out of 3,713

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

10 out of 1,217

The United States of America as Represented by the Department of Health

patents

2 out of 3,817

Johns Hopkins University

patents

4. 1 out of 1

Deutsches Krebsforschungszentrum, the German Cancer Research Center

patent

5. 1 out of 97

New England Medical Center Hospitals. Inc.

patents

where one patent can have more than one assignee

Years Active: 1995-2020

Loading Chart...

Areas of Expertise:

Papillomavirus

Pseudoviruses

Virus-Like Particles

Chimeric Particles

Neutralizing Antibodies

Autoantibodies

Recombinant Proteins

Tumor Detection

Vaccines

Immunization

Expression Inhibitors

Self-Assembly

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10814014 - Papillomavirus pseudoviruses for detection and therapy of tumors (2020-10-27),

2. 10188751 - Papillomavirus pseudoviruses for detection and therapy of tumors (2019-01-29),

3. 9388221 - Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies (2016-07-12),

4. 8999290 - Papillomavirus pseudoviruses for detection and therapy of tumors (2015-04-07),

5. 8404244 - Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies (2013-03-26),

6. 8394411 - Papillomavirus pseudoviruses for detection and therapy of tumors (2013-03-12),

7. 7875450 - Virus-like particles for the induction of autoantibodies (2011-01-25),

8. 7691386 - Chimeric papillomavirus-like particles (2010-04-06),

9. 7479280 - Virus-like particles for the induction of autoantibodies (2009-01-20),

10. 7462356 - Chimeric papillomavirus-like particles (2008-12-09),

11. 7371572 - Mouse titers after two immunizations with VLPs alone (2008-05-13),

12. 7361356 - Self-assembling recombinant papillomavirus capsid proteins (2008-04-22),

13. 7220419 - Self-assembling recombinant papillomavirus capsid proteins (2007-05-22),

14. 6719978 - Virus-like particles for the induction of autoantibodies (2004-04-13),

15. 6599739 - Infectious papillomavirus pseudoviral particles (2003-07-29),

Title: The Innovative Journey of Douglas R. Lowy

Introduction: Douglas R. Lowy, a distinguished inventor hailing from Bethesda, MD (US), has made significant contributions to the field of science and technology through his groundbreaking innovations.

Latest Patents: Douglas R. Lowy holds several patents in the medical and biotechnological sectors, focusing on novel treatments for various diseases and conditions.

Career Highlights: With a career spanning several decades, Douglas R. Lowy has served in key research positions at renowned institutions, leading pioneering projects that have shaped the landscape of modern medicine.

Collaborations: Throughout his career, Douglas R. Lowy has collaborated with top researchers, scientists, and institutions worldwide, fostering a culture of innovation and excellence in his field.

Conclusion: Douglas R. Lowy's relentless pursuit of innovation and his commitment to advancing scientific knowledge have established him as a prominent figure in the world of inventions and patents.

Profile summary based on public USPTO records.